A stepwise multiple regression analysis revealed that the insulin secretory response, the plasma cholesterol level and the relative body weight contributed to the level of plasma TG.
No difference was found in the grades of insulin resistance between patients with and without elevated TG.
The ratio of sum of plasma insulin values to that of blood glucose values during glucose tolerance test was markedly increased in patients with elevated TG. The patients with relatively blunted insulin response and impaired glucose tolerance curves showed only slight hypertriglyceridemia. Endogenous hypertriglyceridemia in obesity seems to be more closely correlated with plasma insulin level, and therefore, with insulin action rather than insulin resistance. endogenous hypertriglyceridemia; obesity; insulin resistance; hyperinsulinemia; insulin secretion Decreased sensitivity to both endogenous and exogenous insulin, or insulin resistance, is one of the characteristics of obese humans with or without diabetes mellitus (Rabinowitz and Zierler 1962; Karam et al. 1963 ; Perley and. Kipnis 1966; Reaven et al. 1970) . Although this insulin resistance has been sometimes attributed to a certain change in adipose tissue (Salans et al. 1968) , in the liver (Wahren et al. 1973) or in the global tissues, its exact etiology has not yet been established. Another abnormal feature frequently observed in obesity is deranged metabolism of endogenous triglyceride (TG); i.e., endogenous hypertriglyceridemia and hepatic TG accumulation (Maruhama et al. 1974 (Maruhama et al. , 1975 . It is interesting that there are definite interrelationships among the levels of plasma endogenous TG released from the liver, liver TG, plasma insulin and over-all insulin sensitivity in non diabetic obese humans (Maruhama et al. 1975 ). It is well-known that insulin resistance is usually accompanied by a compensatory elevation of plasma insulin (Karam et al. 1963; Perley and Kipnis 1966) . It is also well recognized that insulin seriously influences synthesis (Topping and Mayes 1972; Tulloch et al. 1972) and turnover (Havel 1974 ) of endogenous TG. Thus, it is likely that elevated plasma insulin or insulin resistance is responsible for the deranged TG metabolism in obesity. Several authors suggested a close relationship between the elevations of plasma insulin and endogenous TG (Reaven et al. 1967; Ford et al. 1968; Bierman 1972 ); while Glueck et al. (1969) reported a different result. However, since those authors did not examine the insulin sensitivity, the possible role of insulin resistance in hypertriglyceridemia suggested by Havel (1974) could not be ruled out.
This study was performed in order to elucidate whether the elevated plasma insulin or insulin resistance itself is more significantly related to endogenous hypertriglyceridemia in obesity. For this purpose, obese subjects with similar grades of insulin resistance, but with wide ranges of hyperinsulinemia and glucose intolerance, were subjected for the investigations.
SUBJECTS AND METHODS
Eighteen inpatients, 12 males and 6 females, aged 30-60, who showed obesity (relative body weight>115%; see foot-note in Table 1 ) and insulin resistance were the subjects for this investigation. The patients who had diseases other than obesity or mild diabetes, which are known to complicate carbohydrate and lipid disorders, had been excluded. The clinical data of the patients is summarized in Table 1 . Their relative body weights corresponded to 115-165% of standard body weight. All patients had showed a gradual decline in their body weights during the past 1-15 years, though they had shown no acute weight change during the few months before admission. In 10 patients diabetes mellitus had been diagnosed 1-10 years before admission. A family history of diabetes was noted in 33% of the subjects, and this frequency was essentially the same in the subjects with and without diabetes. An incidence of obesity was high (72%) in the family history of those patients.
They had been kept on the standard diet of 1800-2000 kcal per day (ca. 30 kcal/kg), containing 280-300 g of carbohydrate, 40-50 g of fat and 80-90 g of protein, for 2-3 weeks prior to this study. During those periods, various examinations had been carried out in order to rule out the diseases which are known to produce the secondary hypertriglyceridemia.
Their body weights were maintained to within +0.5 kg during those periods. No drugs which may affect the carbohydrate and lipid metabolism were used. After an overnight-fast, the blood specimens were taken from the patients for plasma TG (Van Handel and Zilversmit 1957), total cholesterol (TC) (Zak 1957) , free fatty acids (FFA) (Itaya and Ui 1965) and lipoproteins (Lees and Hatch 1963) . Then, an oral glucose tolerance test (OGTT) using 50 g of glucose was performed. In this test, the capillary and venous blood samples obtained before, and 30, 60, 90 and 120 min after the glucose loading were analysed for blood glucose (Huggett and Nixon 1957) and for plasma insulin (Morgan and Lazarow 1962 ). An intravenous insulin test was performed a few days after OGTT. In this test, blood glucose and plasma FFA levels were measured before, and 15, 30, 45, 60, 90 and 120 min after single i.v. injection of regular insulin (Isuzilin, Shimizu Pharm. Co., Shimizu; 0.1 U/kg).
Insulin sensitivity index, the velocity of blood glucose fall in response to insulin, was calculated as the maximum blood glucose fall from the fasting level (mg/100 ml) divided by time (hr) to the maximum blood glucose fall after i.v. insulin.
In order to test the validity of this index, 7 obese, subjects with hyperinsulinemia and almost normal glucose tolerance were examined for the index before and after weight reduction.
As shown in Fig. 1 , weight reduction and amelioration of hyperinsulinemia was both accompanied by significant increase in the insulin sensitivity index in all cases. Since it is known that overweight and hyperinsulinemia are usually associated with corresponding decrease in insulin sensitivity of tissues, the parallelism of either body weight or plasma insulin level and insulin sensitivity index seems to qualify this index as a nnantitative measure of tissue insulin sensitivity. The present study demonstrated an important role of insulin secretory response in endogenous hypertriglycerideniia of obese, insulin resistant patients. The obese subjects without insulin resistance, hyperinsulinemia and glucose intolerance did not show an elevation in plasma endogenous TG (unpublished observation). Therefore, insulin resistance may cause hyperinsulinemia and hypertriglyceridemia simultaneously, when the insulin secretory function is sufficient. The present study also suggests that in the insulin resistant patients whose insulin secretion is relatively blunted and who show the mildly diabetic glucose tolerance curves, the plasma level of endogenous TG is rather low. There were no differences in the grades of insulin resistance between the patients with and without hypertriglyceridemia in the i.v. insulin test. Thus, elevated plasma insulin, rather than insulin resistance by itself , seems to be closely coupled with the level of plasma endogenous TG. Our previous report (Maruhama et al . 1975) , in which the patients with diabetic glucose tolerance curve (Committee report 1970) were not included, could not indicate quantitative relationships between plasma insulin and TG. It is now clear that in the previous report (Maruhama et al . 1975 ) the patients with insulin resistance and normal or borderline glucose tolerance curve were mostly hyperinsulinemic and hypertriglyceridemmic , and the ranges of both plasma insulin and TG were too small to demonstrate a possible relation ship. The present study supports the results of Reaven et al . (1967) , Ford et al. (1968) and Bierman (1972) , because it showed positive correlation between hyper insulinernia and hypertriglyceridemia. The recent extensive study of Olefsky et al . (1974) demonstrated the essential role of insulin resistance in hypertriglyceridemia in obesity. They measured insulin resistance by glucose , epinephrine and propranolol infusion technique, and confirmed the hypothesis of Reaven et al. (1967) that hyperinsulinemia based on peripheral insulin resistance leads to accelerated hepatic TG production and to hypertriglyceridemia . Though our method used for estimating insulin sensitivity was simple as compared with that of Olefsky et al. (1974) , the present study nevertheless supports the view of Reaven et al. (1967) .
Furthermore, it should be emphasized from the present data that the insulin secretory function of the pancreas is indeed closely related to hypertriglyceridemia, and also that bluntness of this function may rather benefit hypertriglyceridemia in cases of obesity. Insulin resistance would seem to play a certain important role in plasma TG turnover and therefore in hypertriglyceridemia (Havel 1974 ) ; in fact, the patients with insulin resistance but without hyperinsulinemia exhibited slight but significant elevation of plasma TG compared with controls. In spite of this result, the effect of insulin resistance does not seem to be essential so far as hypertriglyceridemia of obesity is concerned. It is not clear whether the patients with relative insulin deficiency and diabetic glucose tolerance curve had ever undergone hyperinsulinemic and more strongly hypertriglyceridemic stage previously, and whether the insulin plethoric hypertri glyceridemic patients can be included in prediabetes.
Since there are no convinc ing data at present as to the relationship between obesity and diabetes mellitus, it is impossible to assume a single disease entity in all insulin resistant patients. However, even if these patients could be classified into two different groups one with diabetes, and the other without diabetes-there is no evidence of biochemical and hormonal differences other than those found in blood glucose and plasma insulin and lipids. No difference was found in plasma glucagon between obese patients without diabetes and with very mild diabetes such as those included in this study (Ishii, personal communication) . And the elevated blood glucose level could not be held responsible for the normal plasma TG level of the obese diabetic patients. Thus, it is very likely that the blunted insulin secretion -rather than diabetic glucose tolerance could account for the TG level of obese mild diabetics which was lower than that of obese non-diabetics.
Of interest is the report of Taketomi et al. (1975) , who showed a parallel reduction of the islet insulin content, hepatic glycolytic and lipogenetic enzymes and plasma TG after streptozotocin treatment in the genetically obese mouse (KK strain). This mouse strain is known to have peripheral insulin resistance, hyper insulinemia, glucose intolerance, increase in hepatic glycolytic and lipogenetic enzymes, fatty liver and endogenous hypertriglyceridemia (Matsuo and Shino 1972; Taketomi et al. 1973 ). These features closely resemble our findings in certain human obesity (Maruhama et al. 1975 ). Since insulin is known to induce the hepatic enzymes which take part in the synthesis of endogenous TG, it is possible that long-lasting hyperinsulinism in the liver is the principal offender in the deranged metabolism of endogenous TG. The report on the streptozotocin-treated KK mouse (Taketomi et al. 1975) suggests that the TG derangement is rather ameliorated with an artificial decompensation of insulin secretory function in the insulin resistant animal. This seems to support the suggestions from this study. Reaven and Reaven (1974) found recently that the numbers of particles of very low density lipoproteins (endogenous TG)in the Golgi complex of the hepatocyte were signifi cantly reduced in the rat with chronic insulin deficiency produced by streptozotocin. They also indicated that the rate of secretion of endogenous TG into plasma from the liver was significantly decreased in such rats . These findings also suggest the important role of plasma insulin concentration in TG metabolism.
In the present study, the elevation of plasma TG was significantly correlated with that of plasma TC. This might indicate that the plasma TC level in obesity is elevated as a result of hypertriglyceridemia, since it is well-known that plasma low density lipoprotein, which is rich in cholesterol, is the metabolic product of very low density lipoprotein in plasma (Bilheimer et al. 1972 ). Finally, there were no correlations between plasma FFA and the other variables. A kinetic study is necessary to know the role of FFA in the lipid disorder, as plasma FFA is known to turn over quickly (Issekutz et al. 1967 ).
